Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Advanced Wound Care Market - Industry Trends and Forecast to 2028

Published by Data Bridge Market Research Private Limited Product code 997285
Published Content info 459 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Advanced Wound Care Market - Industry Trends and Forecast to 2028
Published: February 1, 2021 Content info: 459 Pages
Description

Global advanced wound care market is projected to register a CAGR of 6.3% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028

Market Segmentation:

Global Advanced Wound Care Market, By Product Type (Dressing, Therapy Device, Biologics, Others), Wound Type (Primary Wound Care, Secondary Wound Care), Wound Class (Class I, Class II, Class III, Class IV), End User (Hospitals, Wound Care Centers, Ambulatory Centers, Home Healthcare, Clinics, Others), Distribution Channel (Direct Tenders, Retail), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey & Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific , Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

Some of the major factors contributing to the growth of global advanced wound care market are:

  • Increasing cases of chronic wounds
  • Increasing number of patients undergoing surgical procedures

Market Players:

The key market players for global advanced wound care market are listed below:

  • Smith & Nephew
  • 3M
  • Medline Industries, Inc.
  • Molnlycke Health Care AB
  • ConvaTec Group PLC
  • Baxter
  • Cardinal Health
  • Lohmann & Rauscher GmbH & Co. KG
  • HARTMANN USA, Inc. (a subsidiary of PAUL HARTMANN AG)
  • MiMedx
  • Johnson & Johnson Services, Inc.
  • Integra LifeSciences Corporation
  • Essity Aktiebolag
  • Coloplast Group
  • Organogenesis Inc.
  • B. Braun Melsungen AG
  • Medtronic
  • Hollister Incorporated
  • Zimmer Biomet
  • Elkem ASA
  • TRIAGE MEDITECH PVT. LTD.
  • Brightwake Ltd.
  • DermaRite Industries, LLC
  • Kerecis
Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL ADVANCED WOUND CARE MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 DBMR MARKET POSITION GRID
  • 2.8 DBMR VENDOR SHARE ANALYSIS
  • 2.9 MULTIVARIATE MODELING
  • 2.10 PRODUCT TYPE TIMELINE CURVE
  • 2.11 MARKET END USER COVERAGE GRID
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 GLOBAL ADVANCED WOUND CARE MARKET: LAWS AND REGULATIONS

6 MARKET OVERVIEW

  • 6.1 DRIVERS
    • 6.1.1 INCREASING CASES OF CHRONIC WOUNDS
    • 6.1.2 NEW PRODUCT LAUNCHES
    • 6.1.3 INCREASING NUMBER OF PATIENTS UNDERGOING SURGICAL PROCEDURES
    • 6.1.4 GROWING GERIATRIC POPULATION
    • 6.1.5 RISING AWARENESS PROGRAMS
    • 6.1.6 INCREASING RESEARCH AND DEVELOPMENT
  • 6.2 RESTRAINTS
    • 6.2.1 HIGH COST ASSOCIATED WITH THE TREATMENT
    • 6.2.2 STRINGENT MANUFACTURING POLICIES
    • 6.2.3 PRODUCT RECALL
  • 6.3 OPPORTUNITIES
    • 6.3.1 TECHNOLOGICAL ADVANCEMENT IN WOUND CARE
    • 6.3.2 GROWTH POTENTIAL IN EMERGING ECONOMIES
    • 6.3.3 STRATEGIC INITIATIVES BY THE COMPANIES
  • 6.4 CHALLENGES
    • 6.4.1 LACK OF SKILLED LABOR FORCE
    • 6.4.2 SIDE EFFECTS AND ADVERSE EFFECTS ASSOCIATED WITH CHRONIC WOUNDS
    • 6.4.3 IMPROPER REIMBURSEMENT SCENARIO

7 IMPACT OF COVID-19 ON GLOBAL ADVANCED WOUND CARE MARKET

    • 7.1.1 AFTERMATH OF COVID-19 AND GOVERNMENT ROLE
  • 7.2 STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
  • 7.3 PRICE IMPACT
  • 7.4 IMPACT ON SUPPLY CHAIN
  • 7.5 IMPACT ON DEMAND
  • 7.6 CONCLUSION

8 GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE

  • 8.1 OVERVIEW
  • 8.2 DRESSING
    • 8.2.1 FOAM DRESSING
    • 8.2.2 FILM DRESSING
      • 8.2.2.1 TRANSPARENT
      • 8.2.2.2 NON TRANSPARENT
    • 8.2.3 ALGINATE DRESSING
    • 8.2.4 ANTIMICROBIAL
    • 8.2.5 HYDROGEL DRESSING
    • 8.2.6 COLLAGEN DRESSING
    • 8.2.7 POLYACRYLATE DRESSINGS
    • 8.2.8 SUPER ABSORBENT DRESSING
      • 8.2.8.1 NON- ADHERENT
      • 8.2.8.2 ADHERENT
    • 8.2.9 WOUND CONTACT LAYER
    • 8.2.10 WOUND CLEANSERS
    • 8.2.11 HONEY DRESSINGS
  • 8.3 THERAPY DEVICES
    • 8.3.1 NEGATIVE PRESSURE WOUND THERAPY (NPWT)
      • 8.3.1.1 DISPOSABLE NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES
      • 8.3.1.2 PORTABLE NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES
      • 8.3.1.3 STANDALONE NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES
    • 8.3.2 PHYSICAL THERAPIES
      • 8.3.2.1 LASER THERAPY
      • 8.3.2.2 EXTERNAL SHOCK WAVE THERAPIES
      • 8.3.2.3 ELECTRICAL STIMULATION
      • 8.3.2.4 SALINE MIST THERAPY
    • 8.3.3 PRESSURE RELIEF DEVICES
      • 8.3.3.1 MATTRESS
      • 8.3.3.2 BED
    • 8.3.4 HYPERBARIC OXYGEN CHAMBERS
      • 8.3.4.1 MONOPLACE
      • 8.3.4.2 MULTIPLACE
      • 8.3.4.3 TOPICAL
    • 8.3.5 WOUND DEBRIDEMENT DEVICES
      • 8.3.5.1 ULTRASOUND
      • 8.3.5.2 HYDROSURGICAL
      • 8.3.5.3 MECHANICAL
      • 8.3.5.4 OTHERS
  • 8.4 BIOLOGICS
    • 8.4.1 ALLOGRAFTS
      • 8.4.1.1 CULTURED ALLOGRAFTS
      • 8.4.1.2 HUMAN DERMAL LAYER
    • 8.4.2 XENOGRAFTS
    • 8.4.3 SYNTHETIC SKIN GRAFTS
    • 8.4.4 GROWTH FACTORS
      • 8.4.4.1 PLATELET DERIVED GROWTH FACTORS (PDGF)
      • 8.4.4.2 PLATELET RICH PLASMA (PRP)
      • 8.4.4.3 EPIDERMAL GROWTH FACTORS (EGF)
      • 8.4.4.4 GRANULOCYTE COLONY STIMULATING FACTORS (G-CSF)
      • 8.4.4.5 BASIC FIBROBLAST GROWTH FACTORS (BFGF)
      • 8.4.4.6 KERATINOCYTE GROWTH FACTORS (KGF)
      • 8.4.4.7 TALACTOFERRIN ALFA
      • 8.4.4.8 THROMBIN PEPTIDE (TP508)
  • 8.5 OTHERS

9 GLOBAL ADVANCED WOUND CARE MARKET, BY WOUND CLASS

  • 9.1 OVERVIEW
  • 9.2 CLASS III
  • 9.3 CLASS IV
  • 9.4 CLASS II
  • 9.5 CLASS I

10 GLOBAL ADVANCED WOUND CARE MARKET, BY WOUND TYPE

  • 10.1 OVERVIEW
  • 10.2 PRIMARY WOUND CARE
    • 10.2.1 SURGICAL INCISIONS
    • 10.2.2 ULCERS
      • 10.2.2.1 DIABETIC FOOT ULCERS
      • 10.2.2.2 PRESSURE ULCERS
      • 10.2.2.3 VENOUS ULCERS
    • 10.2.3 PAPER CUTS
    • 10.2.4 SMALL CUTANEOUS WOUNDS
  • 10.3 SECONDARY WOUND CARE
    • 10.3.1 TRAUMATIC WOUNDS
    • 10.3.2 BURNS
      • 10.3.2.1 THERMAL BURN
      • 10.3.2.2 ELECTRICAL BURN
      • 10.3.2.3 CHEMICAL BURN
      • 10.3.2.4 RADIATION BURN
      • 10.3.2.5 FRICTION BURN

11 GLOBAL ADVANCED WOUND CARE MARKET, BY END USER

  • 11.1 OVERVIEW
  • 11.2 HOPSITALS
  • 11.3 WOUND CARE CENTERS
  • 11.4 AMBULATORY CENTERS
  • 11.5 HOME HEALTH CARE
  • 11.6 CLINICS
  • 11.7 OTHERS

12 GLOBAL ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL

  • 12.1 OVERVIEW
  • 12.2 DIRECT TENDERS
  • 12.3 RETAIL

13 GLOBAL ADVANCED WOUND CARE MARKET, BY GEOGRAPHY

  • 13.1 OVERVIEW
  • 13.2 NORTH AMERICA
    • 13.2.1 U.S.
    • 13.2.2 CANADA
    • 13.2.3 MEXICO
  • 13.3 EUROPE
    • 13.3.1 GERMANY
    • 13.3.2 FRANCE
    • 13.3.3 U.K.
    • 13.3.4 ITALY
    • 13.3.5 SPAIN
    • 13.3.6 RUSSIA
    • 13.3.7 NETHERLANDS
    • 13.3.8 SWITZERLAND
    • 13.3.9 BELGIUM
    • 13.3.10 TURKEY
    • 13.3.11 REST OF EUROPE
  • 13.4 ASIA-PACIFIC
    • 13.4.1 JAPAN
    • 13.4.2 CHINA
    • 13.4.3 AUSTRALIA
    • 13.4.4 SOUTH KOREA
    • 13.4.5 INDIA
    • 13.4.6 INDONESIA
    • 13.4.7 THAILAND
    • 13.4.8 SINGAPORE
    • 13.4.9 MALAYSIA
    • 13.4.10 PHILIPPINE
    • 13.4.11 REST OF ASIA-PACIFIC
  • 13.5 SOUTH AMERICA
    • 13.5.1 BRAZIL
    • 13.5.2 ARGENTINA
    • 13.5.3 REST OF SOUTH AMERICA
  • 13.6 MIDDLE EAST & AFRICA
    • 13.6.1 SOUTH AFRICA
    • 13.6.2 SAUDI ARABIA
    • 13.6.3 UAE
    • 13.6.4 EGYPT
    • 13.6.5 ISRAEL
    • 13.6.6 REST OF MIDDLE EAST & AFRICA

14 GLOBAL ADVANCED WOUND CARE MARKET: COMPANY LANDSCAPE

  • 14.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 14.3 COMPANY SHARE ANALYSIS: EUROPE
  • 14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

15 SWOT ANALYSIS

16 COMPANY PREFOLE

  • 16.1 SMITH & NEPHEW
    • 16.1.1 COMPANY SNAPSHOT
    • 16.1.2 REVENUE ANALYSIS
    • 16.1.3 COMPANY SHARE ANALYSIS
    • 16.1.4 PRODUCT PORTFOLIO
    • 16.1.5 RECENT DEVELOPMENTS
  • 16.2 3M
    • 16.2.1 COMPANY SNAPSHOT
    • 16.2.2 REVENUE ANALYSIS
    • 16.2.3 COMPANY SHARE ANALYSIS
    • 16.2.4 PRODUCT PORTFOLIO
    • 16.2.5 RECENT DEVELOPMENT
  • 16.3 MEDLINE INDUSTRIES, INC.
    • 16.3.1 COMPANY SNAPSHOT
    • 16.3.2 COMPANY SHARE ANALYSIS
    • 16.3.3 PRODUCT PORTFOLIO
    • 16.3.4 RECENT DEVELOPMENTS
  • 16.4 MOLNLYCKE HEALTH CARE AB
    • 16.4.1 COMPANY SNAPSHOT
    • 16.4.2 COMPANY SHARE ANALYSIS
    • 16.4.3 PRODUCT PORTFOLIO
    • 16.4.4 RECENT DEVELOPMENTS
  • 16.5 CONVATEC GROUP PLC
    • 16.5.1 COMPANY SNAPSHOT
    • 16.5.2 REVENUE ANALYSIS
    • 16.5.3 PRODUCT PORTFOLIO
    • 16.5.4 RECENT DEVELOPMENTS
  • 16.6 BAXTER
    • 16.6.1 COMPANY SNAPSHOT
    • 16.6.2 REVENUE ANALYSIS
    • 16.6.3 PRODUCT PORTFOLIO
    • 16.6.4 RECENT DEVELOPMENTS
  • 16.7 CARDINAL HEALTH
    • 16.7.1 COMPANY SNAPSHOT
    • 16.7.2 REVENUE ANALYSIS
    • 16.7.3 PRODUCT PORTFOLIO
    • 16.7.4 RECENT DEVELOPMENTS
  • 16.8 B. BRAUN MELSUNGEN AG
    • 16.8.1 COMPANY SNAPSHOT
    • 16.8.2 REVENUE ANALYSIS
    • 16.8.3 PRODUCT PORTFOLIO
    • 16.8.4 RECENT DEVELOPMENTS
  • 16.9 BRIGHTWAKE LTD.
    • 16.9.1 COMPANY SNAPSHOT
    • 16.9.2 PRODUCT PORTFOLIO
    • 16.9.3 RECENT DEVELOPMENT
  • 16.10 COLOPLAST GROUP
    • 16.10.1 COMPANY SNAPSHOT
    • 16.10.2 REVENUE ANALYSIS
    • 16.10.3 PRODUCT PORTFOLIO
    • 16.10.4 RECENT DEVELOPMENTS
  • 16.11 DERMARITE INDUSTRIES, LLC
    • 16.11.1 COMPANY SNAPSHOT
    • 16.11.2 PRODUCT PORTFOLIO
    • 16.11.3 RECENT DEVELOPMENT
  • 16.12 ELKEM ASA
    • 16.12.1 COMPANY SNAPSHOT
    • 16.12.2 REVENUE ANALYSIS
    • 16.12.3 PRODUCT PORTFOLIO
    • 16.12.4 RECENT DEVELOPMENTS
  • 16.13 ESSITY AKTIEBOLAG
    • 16.13.1 COMPANY SNAPSHOT
    • 16.13.2 REVENUE ANALYSIS
    • 16.13.3 PRODUCT PORTFOLIO
    • 16.13.4 RECENT DEVELOPMENTS
  • 16.14 HOLLISTER INCORPORATED
    • 16.14.1 COMPANY SNAPSHOT
    • 16.14.2 PRODUCT PORTFOLIO
    • 16.14.3 RECENT DEVELOPMENTS
  • 16.15 INTEGRA LIFESCIENCES CORPORATION
    • 16.15.1 COMPANY SNAPSHOT
    • 16.15.2 REVENUE ANALYSIS
    • 16.15.3 PRODUCT PORTFOLIO
    • 16.15.4 RECENT DEVELOPMENTS
  • 16.16 JOHNSON & JOHNSON SERVICES, INC.
    • 16.16.1 COMPANY SNAPSHOT
    • 16.16.2 REVENUE ANALYSIS
    • 16.16.3 PRODUCT PORTFOLIO
    • 16.16.4 RECENT DEVELOPMENT
  • 16.17 KERECIS
    • 16.17.1 COMPANY SNAPSHOT
    • 16.17.2 PRODUCT PORTFOLIO
    • 16.17.3 RECENT DEVELOPMENTS
  • 16.18 LOHMANN & RAUSCHER GMBH & CO. KG
    • 16.18.1 COMPANY SNAPSHOT
    • 16.18.2 PRODUCT PORTFOLIO
    • 16.18.3 RECENT DEVELOPMENTS
  • 16.19 MEDTRONIC
    • 16.19.1 COMPANY SNAPSHOT
    • 16.19.2 REVENUE ANALYSIS
    • 16.19.3 PRODUCT PORTFOLIO
    • 16.19.4 RECENT DEVELOPMENT
  • 16.20 MIMEDX
    • 16.20.1 COMPANY SNAPSHOT
    • 16.20.2 REVENUE ANALYSIS
    • 16.20.3 PRODUCT PORTFOLIO
    • 16.20.4 RECENT DEVELOPMENTS
  • 16.21 ORGANOGENESIS INC.
    • 16.21.1 COMPANY SNAPSHOT
    • 16.21.2 REVENUE ANALYSIS
    • 16.21.3 PRODUCT PORTFOLIO
    • 16.21.4 RECENT DEVELOPMENTS
  • 16.22 HARTMANN USA, INC. (A SUBSIDIARY OF PAUL HARTMANN AG)
    • 16.22.1 COMPANY SNAPSHOT
    • 16.22.2 REVENUE ANALYSIS
    • 16.22.3 PRODUCT PORTFOLIO
    • 16.22.4 RECENT DEVELOPMENTS
  • 16.23 TRIAGE MEDITECH PVT. LTD.
    • 16.23.1 COMPANY SNAPSHOT
    • 16.23.2 PRODUCT PORTFOLIO
    • 16.23.3 RECENT DEVELOPMENT
  • 16.24 ZIMMER BIOMET
    • 16.24.1 COMPANY SNAPSHOT
    • 16.24.2 REVENUE ANALYSIS
    • 16.24.3 PRODUCT PORTFOLIO
    • 16.24.4 RECENT DEVELOPMENT

17 QUESTIONNAIRE

18 RELATED REPORTS

LIST OF FIGURES

  • FIGURE 1 GLOBAL ADVANCED WOUND CARE MARKET: SEGMENTATION 60
  • FIGURE 2 GLOBAL ADVANCED WOUND CARE MARKET: DATA TRIANGULATION 63
  • FIGURE 3 GLOBAL ADVANCED WOUND CAREMARKET: DROC ANALYSIS 64
  • FIGURE 4 GLOBAL ADVANCED WOUND CARE MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 65
  • FIGURE 5 GLOBAL ADVANCED WOUND CARE MARKET: COMPANY RESEARCH ANALYSIS 65
  • FIGURE 6 GLOBAL ADVANCED WOUND CARE MARKET: INTERVIEW DEMOGRAPHICS 66
  • FIGURE 7 GLOBAL ADVANCED WOUND CARE MARKET: DBMR MARKET POSITION GRID 67
  • FIGURE 8 GLOBAL ADVANCED WOUND CARE MARKET: DBMR VENDOR SHARE ANALYSIS 69
  • FIGURE 9 GLOBAL ADVANCED WOUND CARE MARKET: MARKET END USER COVERAGE GRID 72
  • FIGURE 10 GLOBAL ADVANCED WOUND CARE MARKET: SEGMENTATION 76
  • FIGURE 11 INCREASING CASES OF CHRONIC WOUNDS IS EXPECTED TO DRIVE THE GLOBAL ADVANCED WOUND CARE MARKET IN THE FORECAST PERIOD OF 2021 TO 2028 77
  • FIGURE 12 DRESSING SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL ADVANCED WOUND CARE MARKET IN 2021 & 2028 77
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL ADVANCED WOUND CARE MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028 78
  • FIGURE 14 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR ADVANCED WOUND CARE MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028 79
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL ADVANCED WOUND CARE MARKET 86
  • FIGURE 16 TOP TEN COUNTRIES/TERRITORIES FOR NUMBER OF NEW CASES OF TYPE 1 DIABETES (CHILDREN AND ADOLESCENTS <20 YEARS), PER YEAR 87
  • FIGURE 17 HEALTHCARE EXPENDITURE IN FEW COUNTRIES (2016 & 2019) 92
  • FIGURE 18 GLOBAL ADVANCED WOUND CARE MARKET: BY PRODUCT TYPE, 2020 104
  • FIGURE 19 GLOBAL ADVANCED WOUND CARE MARKET: BY PRODUCT TYPE, 2020-2028 (USD MILLION) 105
  • FIGURE 20 GLOBAL ADVANCED WOUND CARE MARKET: BY PRODUCT TYPE, CAGR (2020-2028) 105
  • FIGURE 21 GLOBAL ADVANCED WOUND CARE MARKET: BY PRODUCT TYPE, LIFELINE CURVE 106
  • FIGURE 22 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND CLASS, 2020 120
  • FIGURE 23 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND CLASS, 2020-2028 (USD MILLION) 121
  • FIGURE 24 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND CLASS, CAGR (2020-2028) 121
  • FIGURE 25 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND CLASS, LIFELINE CURVE 122
  • FIGURE 26 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND TYPE, 2020 127
  • FIGURE 27 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND TYPE, 2020-2028 (USD MILLION) 128
  • FIGURE 28 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND TYPE, CAGR (2020-2028) 128
  • FIGURE 29 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND TYPE, LIFELINE CURVE 129
  • FIGURE 30 GLOBAL ADVANCED WOUND CARE MARKET: BY END USER, 2020 135
  • FIGURE 31 GLOBAL ADVANCED WOUND CARE MARKET: BY END USER, 2020-2028 (USD MILLION) 136
  • FIGURE 32 GLOBAL ADVANCED WOUND CARE MARKET: BY END USER, CAGR (2020-2028) 136
  • FIGURE 33 GLOBAL ADVANCED WOUND CARE MARKET: BY END USER, LIFELINE CURVE 137
  • FIGURE 34 GLOBAL ADVANCED WOUND CARE MARKET: BY DISTRIBUTION CHANNEL, 2020 143
  • FIGURE 35 GLOBAL ADVANCED WOUND CARE MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION) 144
  • FIGURE 36 GLOBAL ADVANCED WOUND CARE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028) 144
  • FIGURE 37 GLOBAL ADVANCED WOUND CARE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 145
  • FIGURE 38 GLOBAL ADVANCED WOUND CARE MARKET: SNAPSHOT (2020) 150
  • FIGURE 39 GLOBAL ADVANCED WOUND CARE MARKET: BY COUNTRY (2020) 151
  • FIGURE 40 GLOBAL ADVANCED WOUND CARE MARKET: BY COUNTRY (2020 & 2028) 151
  • FIGURE 41 GLOBAL ADVANCED WOUND CARE MARKET: BY COUNTRY (2020 & 2028) 152
  • FIGURE 42 GLOBAL ADVANCED WOUND CARE MARKET: BY TYPE (2020-2028) 152
  • FIGURE 43 NORTH AMERICA ADVANCED WOUND CARE MARKET : SNAPSHOT (2020) 154
  • FIGURE 44 NORTH AMERICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020) 155
  • FIGURE 45 NORTH AMERICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 155
  • FIGURE 46 NORTH AMERICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 156
  • FIGURE 47 NORTH AMERICA ADVANCED WOUND CARE MARKET : BY TYPE (2020-2028) 156
  • FIGURE 48 EUROPE ADVANCED WOUND CARE MARKET : SNAPSHOT (2020) 181
  • FIGURE 49 EUROPE ADVANCED WOUND CARE MARKET : BY COUNTRY (2020) 182
  • FIGURE 50 EUROPE ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 182
  • FIGURE 51 EUROPE ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 183
  • FIGURE 52 EUROPE ADVANCED WOUND CARE MARKET : BY TYPE (2020-2028) 183
  • FIGURE 53 ASIA-PACIFIC ADVANCED WOUND CARE MARKET : SNAPSHOT (2020) 252
  • FIGURE 54 ASIA-PACIFIC ADVANCED WOUND CARE MARKET : BY COUNTRY (2020) 253
  • FIGURE 55 ASIA-PACIFIC ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 253
  • FIGURE 56 ASIA-PACIFIC ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 254
  • FIGURE 57 ASIA-PACIFIC ADVANCED WOUND CARE MARKET : BY TYPE (2020-2028) 254
  • FIGURE 58 SOUTH AMERICA ADVANCED WOUND CARE MARKET : SNAPSHOT (2020) 323
  • FIGURE 59 SOUTH AMERICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020) 324
  • FIGURE 60 SOUTH AMERICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 324
  • FIGURE 61 SOUTH AMERICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 325
  • FIGURE 62 SOUTH AMERICA ADVANCED WOUND CARE MARKET : BY TYPE (2020-2028) 325
  • FIGURE 63 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET : SNAPSHOT (2020) 345
  • FIGURE 64 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020) 346
  • FIGURE 65 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 346
  • FIGURE 66 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 347
  • FIGURE 67 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET : BY TYPE (2020-2028) 347
  • FIGURE 68 GLOBAL ADVANCED WOUND CARE MARKET: COMPANY SHARE 2020 (%) 385
  • FIGURE 69 NORTH AMERICA ADVANCED WOUND CARE MARKET: COMPANY SHARE 2020 (%) 386
  • FIGURE 70 EUROPE ADVANCED WOUND CARE MARKET: COMPANY SHARE 2020 (%) 387
  • FIGURE 71 ASIA-PACIFIC ADVANCED WOUND CARE MARKET: COMPANY SHARE 2020 (%) 388
Back to Top